Humoral and cellular responses to a fifth bivalent SARS-CoV-2 vaccine dose in patients with immune-mediated inflammatory diseases on tumour necrosis factor inhibitors: a prospective cohort study
The South-Eastern Norway Regional Health Authority, The Coalition for Epidemic Preparedness Innovations (CEPI), Diakonhjemmet Hospital, Akershus University Hospital, Oslo University Hospital, University of Oslo, The Norwegian Research Council.
Authors
- Jørgen Jahnsen (ORCID: https://orcid.org/0000-0002-0419-2914)
- Kristin Kaasen Jørgensen (ORCID: https://orcid.org/0000-0002-3693-7706)
- Hilde S Ørbo (ORCID: https://orcid.org/0000-0002-0957-1681)
- Silje Watterdal Syversen (ORCID: https://orcid.org/0000-0003-2159-3696)
- John Torgils Vaage (ORCID: https://orcid.org/0000-0003-0988-5768)
- Andreas Lind (ORCID: https://orcid.org/0000-0002-8289-8410)
- Tore Kristian Kvien (ORCID: https://orcid.org/0000-0002-8441-3093)
- K. H. Bjørlykke (ORCID: https://orcid.org/0000-0003-2369-6760)
- Anne Therese Tveter (ORCID: https://orcid.org/0000-0003-1701-9835)
- Asia‐Sophia Wolf (ORCID: https://orcid.org/0000-0003-1982-9487)
- Sabin Bhandari (ORCID: https://orcid.org/0000-0003-3837-027X)
- Gunnveig Grødeland
- Guro Løvik Goll (ORCID: https://orcid.org/0000-0002-8506-725X)
- Hassen Kared (ORCID: https://orcid.org/0000-0002-8220-997X)
- Ludvig A. Munthe (ORCID: https://orcid.org/0000-0002-0344-3654)
- Ingrid Jyssum (ORCID: https://orcid.org/0000-0003-1412-9713)
- Siri Mjaaland (ORCID: https://orcid.org/0000-0002-3870-5861)
- Sella Aarrestad Provan (ORCID: https://orcid.org/0000-0001-5442-902X)
- Ingrid Fadum Kjønstad (ORCID: https://orcid.org/0000-0001-5306-3492)
- Ingrid Christensen (ORCID: https://orcid.org/0000-0002-8429-8152)
- Guri Solum (ORCID: https://orcid.org/0000-0002-5269-5727)
- Espen A Haavardsholm (ORCID: https://orcid.org/0000-0002-5893-1698)
- Joseph Sexton
- Taissa de Matos Kasahara
Institutions
- Oslo University Hospital (NO)
- Norwegian Institute of Public Health (NO)
- University of Oslo (NO)
- Akershus University Hospital (NO)
- University of Inland Norway (NO)
- Diakonhjemmet Hospital (NO)
Publication Details
- Journal
- The Lancet Regional Health - Europe
- Published
- 2024-11-15
- DOI
- https://doi.org/10.1016/j.lanepe.2024.101121
- Citations
- 1
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 0.39
Funders
- Eli Lilly and Company
- Pfizer
- AstraZeneca
- Sanofi
- AbbVie
- Coalition for Epidemic Preparedness Innovations
- Moderna
- Universitetet i Oslo
- Norges Forskningsråd
- Diakonhjemmet
- Akershus Universitetssykehus
- Ipsen
- Seqirus
- Norgine
- Helse Sør-Øst RHF
- Norwegian Institute of Public Health